Chronic hives (chronic urticaria) clinical trials in Alabama

Medical name: Chronic urticaria · Skin

3 trials are recruiting in Alabama. Trial details are from ClinicalTrials.gov; a trial marked "screening open" is taking people in Alabama at a site the registry does not list yet.

Checked against the registry on 14 October 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.

Recruiting · Phase 2 · Listed on Beacon

An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria

Ages 18 Years to 65 Years · 3 sites · screening open for people in Alabama · ARS Pharmaceuticals, Inc.

Details and how to check if you qualify · NCT06927999 on ClinicalTrials.gov

Recruiting · Phase 3

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

Ages 18 Years to no maximum · 72 sites · in Alabama: Birmingham · Celldex Therapeutics

NCT07266402 on ClinicalTrials.gov

Enrolling by invitation · Phase 3

Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Ages 18 Years to no maximum · 182 sites · in Alabama: Birmingham · Celldex Therapeutics

NCT07256392 on ClinicalTrials.gov